kabutan

Mochida Pharmaceutical Co.,Ltd.(4534) Summary

4534
TSE Prime
Mochida Pharmaceutical Co.,Ltd.
3,310
JPY
-10
(-0.30%)
Dec 5, 2:22 pm JST
21.37
USD
Dec 5, 12:22 am EST
Result
PTS
outside of trading hours
3,308.5
Dec 5, 1:43 pm JST
Summary Chart Historical News Financial Result
PER
21.7
PBR
0.87
Yield
2.42%
Margin Trading Ratio
2.86
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
3,300 JPY 21.27 USD
Previous Close Dec 4
3,320 JPY 21.36 USD
High Dec 5, 9:20 am
3,340 JPY 21.53 USD
Low Dec 5, 12:37 pm
3,295 JPY 21.24 USD
Volume
10,900
Trading Value
0.04B JPY 0.23M USD
VWAP
3314.59 JPY 21.42 USD
Minimum Trading Value
331,000 JPY 2,137 USD
Market Cap
0.12T JPY 0.78B USD
Number of Trades
70
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
105
1-Year High Nov 4, 2025
649
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 2,000 11,900 5.95
Nov 21, 2025 2,000 13,300 6.65
Nov 14, 2025 27,500 18,700 0.68
Nov 7, 2025 15,900 34,700 2.18
Oct 31, 2025 14,200 29,300 2.06
Company Profile
Mochida Pharmaceutical Co., Ltd. is a mid-tier pharmaceutical company. Its main product is a medication for hyperlipidemia. The company has strengths in antihypertensive drugs and obstetrics and gynecology products. It also operates in the healthcare sector.
Sector
Pharmaceuticals
While the pharmaceutical-related business is the company's core operation, accounting for the majority of its sales, Mochida Pharmaceutical also engages in the healthcare business. In the pharmaceutical-related business, the company outsources manufacturing to its subsidiary, Mochida Pharmaceutical Plant Co., Ltd., and handles the procurement and sales of these products. Some pharmaceuticals are sold through Mochida Pharmaceutical Sales Co., Ltd. In the healthcare business, the subsidiary Mochida Healthcare Co., Ltd. is responsible for product procurement and sales. Manufacturing for healthcare products is also outsourced to Mochida Pharmaceutical Plant Co., Ltd., similar to pharmaceuticals. The group also includes subsidiaries that handle real estate brokerage, management of buildings and structures, and provide proxy services for accounting and purchasing operations, which Mochida Pharmaceutical also utilizes.